Key terms
About QNCX
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest QNCX news
No recent press releases are available for QNCX
QNCX Financials
Key terms
Ad Feedback
QNCX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
QNCX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range